Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:03:26.936Z.
Calculation as of: 2026-10-06T17:03:26.936Z.
Quote observation: 2026-10-06T17:00:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3dc852dbbee421fd1d0f2104bcbe090e37fdd8a7ae3294fdff0c13dff3b4c360
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$2.33B
EV/EBIT Ratio
12.91x
TTM Avg
116.99x
3Y Avg
116.99x
5Y Avg
116.99x
Market Cap
$2.37B
EV/EBIT Ratio
11.28x
TTM Avg
17.19x
3Y Avg
119.55x
5Y Avg
119.55x
Market Cap
$2.30B
EV/EBIT Ratio
8.24x
TTM Avg
7.33x
3Y Avg
8.48x
5Y Avg
15.70x
Market Cap
$2.39B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.28B
EV/EBIT Ratio
24.89x
TTM Avg
17.43x
3Y Avg
12.93x
5Y Avg
8.03x
Market Cap
$2.40B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.42B
EV/EBIT Ratio
N/A
TTM Avg
30.85x
3Y Avg
58.02x
5Y Avg
40.57x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | $2.34B | N/A | N/A | N/A | N/A |
| Liquidia Corporation (LQDA)vs › | $2.33B | 12.91x | 116.99x | 116.99x | 116.99x |
| ADMA Biologics, Inc. (ADMA)vs › | $2.37B | 11.28x | 17.19x | 119.55x | 119.55x |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.30B | 8.24x | 7.33x | 8.48x | 15.70x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.39B | N/A | N/A | N/A | N/A |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.28B | 24.89x | 17.43x | 12.93x | 8.03x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | N/A | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.42B | N/A | N/A | N/A | N/A |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.42B | N/A | 30.85x | 58.02x | 40.57x |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
